Long-term immunologic effects of thymectomy in patients with myasthenia gravis

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 5 II, 1999, Pages 865-872

  Gerli, Roberto ^a,h   Paganelli, Roberto ^b   Cossarizza, Andrea ^c   Muscat, Christopher ^a   Piccolo, Giovanni ^d   Barbieri, Daniela ^c   Mariotti, Stefano ^e   Monti, Daniela ^c   Bistoni, Onelia ^a   Raiola, Elda ^d   Venanzi, Franco Maria ^f   Bertotto, Alberto ^a   Franceschi, Claudio ^g  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

^f UNIVERSITY OF CAMERINO   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h POLICLINICO MONTELUCE   (Italy)

Author keywords

Anti DNA; Anticardiolipin; B cell; Myasthenia gravis; Systemic lupus erythematosus; T cell; Thymectomy

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CD19 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; THYROID ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTOPENIA; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION; THYMECTOMY; TREATMENT OUTCOME;

EID: 0033022145     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70431-8     Document Type: Article

References (62)

1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;30:1797-810.
2. Lewis RA, Selwa JF, Lisak RP. Myasthenia gravis: immunological mechanisms and immunotherapy. Ann Neurol 1995;37:51-62.
3. Oosterhuis H. Observations of the natural history of myasthenia gravis and effect of thymectomy. Ann NY Acad Sci 1981;377:678-84.
4. Rowland LP. General discussion on therapy in myasthenia gravis. Ann NY Acad Sci 1987;505:607-9.
5. Olanow CW, Wechsler AS, Sirotkin-Roses M, Stajich J, Roses AD. Thymectomy as primary therapy in myasthenia gravis. Ann NY Acad Sci 1987;505:595-606.
6. Perlo VP, Arnason B, Castleman B. The thymus gland in elderly patients with myasthenia gravis. Neurology 1975;25:294-5.
7. Alarcon-Segovia D, Gallbraith RF, Maldonado JE. Systemic lupus erythematosus following thymectomy for myasthenia gravis: report of two cases. Lancet 1963;2:662-5.
8. Simpson JA. Immunological disturbances in myasthenia gravis with a report of Hashimoto's disease developing after thymectomy. J Neurol Neurosurg Psychiatry 1964;27:485-92.
9. Gallbraith RF, Summerskill WHJ, Murray J. Systemic lupus erythematosus, cirrhosis and ulcerative colitis after thymectomy for myasthenia gravis. N Engl J Med 1964;278:229-32.
10. Petersen P, Lund J. Systemic lupus erythematosus following thymectomy for myasthenia gravis. Dan Med Bull 1969;16:179-81.
11. Kennes B, Delespesse G, Vandenbosche JL, Sternon J. Systemic lupus erythematosus triggered by adult thymectomy for myasthenia gravis: report of a case. Acta Clin Belg 1978;33:2-6.
12. Abruzzese G, Abruzzese M, Bacigalupo A, Ratto S. Systemic lupus erythematosus after thymectomy in a patient with myasthenia gravis. Neurology 1979;29:1436-7.
13. Mizon JP, Morcamp D, Lefebvre P, Froissart M, Guidicelli CP, Goasgen J, et al. Associated myasthenia and systemic lupus erythematosus: a report of two cases and review of the literature. Ann Med Interne (Paris) 1979;11:489-500.
14. Calabrese LH, Bach JF, Currie T. Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. Arch Intern Med 1981;141:253-5.
15. Goldman M, Herode A, Borenstein S, Zanen A. Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arthritis Rheum 1984;27:701-3.
16. Szobor A. Benefit of thymectomy in immune diseases other than myasthenia. Lancet 1984;1:277-8.
17. Harati Y, Niaken E. Thymectomy for autoimmune disease other than rheumatoid arthritis [letter]. Lancet 1984;1:792.
18. Grinlinton FM, Linch NM, Hart HH. A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Arthritis Rheum 1991;34:916-9.
19. Hassel B, Glhus NE, Aarli JA. Fulminant myasthenia gravis and polymyositis after thymectomy for thymoma. Acta Neurol Scand 1992;85:63-5.
20. Mevorach D, Perrot S, Buchanan NM, Khamashta M, Laoussadi S, Hughes GR, et al. Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus 1995;4:33-7.
21. Sant SM. Systemic lupus erythematosus after thymectomy in a patient with myasthenia gravis [letter]. Ir Med J 1997;90:116.
22. Shoenfeld Y, Lorber M, Yucel T, Yazici H. Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: additional evidence for the kaleidoscope of autoimmunity. Lupus 1997;6:474-6.
23. Haberhauer G, Fries W, Hinterberger W. Arthritis, cutaneous vasculitis and autoantibody multiplicity following thymectomy for pure red cell aplasia. Clin Exp Rheumatol 1993;11:459-60.
24. Osserman KE. Myasthenia gravis. New York: Grune & Stratton; 1958.
25. Ligthart GJ, Corberand JX, Geertzen HGM, Meinders AE, Knook DL, Hijmans W. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR Protocol. Mech Ageing Dev 1990;55:89-97.
26. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993;80:2767-73.
27. Cossarizza A, Ortolani C, Mussini C, Guaraldi G, Mongiardo N, Borghi V, et al. Lack of selective Vβ deletion in CD4+ or CD8+ lymphocytes during acute HIV syndrome. AIDS 1995;9:547-54.
28. Posnett DN, Sinha R, Kabak S, Russo C. Clonal population of T cell in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy." J Exp Med 1994;179:609-18.
29. Cossarizza A, Ortolani C, Forti E, Montagnani G, Paganelli R, Zannotti M, et al. Age-related expansion of functionally inefficient cells with markers of NK activity in Down's syndrome. Blood 1991;77:1263-70.
30. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:185-9.
31. Jefferis R, Reimer CB, Skvaril F, de Lange G, Ling NR, Lowe J, et al. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of an IUIS/WHO collaborative study. Immunol Lett 1985;10:223-52.
32. Molden DP, Nakamura RM, Tan EM. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. Am J Clin Pathol 1984;82:57-66.
33. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
34. Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992;339:1506-8.
35. Martino G, Twaddle G, Brambilla E, Grimaldi LM. Detection of antiacetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line. Acta Neurol Scand 1994;89:18-22.
36. Chan MKL, Britton M. Comparative clinical features in patients with myasthenia gravis with systemic lupus erythematosus. J Rheumatol 1980;7:838-42.
37. Tola MR, Casetta I, Granieri E, Caniatti LM, Monetti VC, Pascarella R. Systemic lupus erythematosus related recurrent transverse myelitis in a patient with myasthenia gravis and multiple sclerosis. Eur Neurol 1996;36:327-8.
38. de Carvalho MF, Abrahao TC, Assaf M. Systemic lupus erythematosus and myasthenia gravis: case report. Arq Neuropsiquiatr 1998;56:137-40.
39. Gershwin MG, Glinski W, Bender AN, Ringel SP, Engel WK. Antibodies to nucleic acids in myasthenia gravis. Int Arch Allergy 1976;51:245-52.
40. Fischbach M, Lindstrom J, Talal N. Antibodies to polyadenylic acid in patients with myasthenia gravis. Clin Exp Immunol 1981;43:73-9.
41. Smeenk R, Van der Lelij G, Swaak T, Groenwold J, Aarden L. Specificity in systemic lupus erythematosus of antibodies to double-stranded DNA measured with the polyethylene glycol precipitation assay. Arthritis Rheum 1982;25:631-8.
42. Sanmarco M, Bernard D. Studies of IgG-class anticardiolipin antibodies in myasthenia gravis. Autoimmunity 1994;18:57-63.
43. Valesini G, Pastore R, De Berardinis PG, Serafini U, Vincent A, Bottazzo GF. Appearance of anti-acetylcholine receptor antibodies coincident with onset of myasthenic weakness in patient with systemic lupus erythematosus [letter]. Lancet 1983;1:831.
44. Sherer Y, Bar-Dayan Y, Shoenfeld Y Thymectomy and autoimmune diseases. The dual connection. Sem Clin Immunol 1997;1:5-11.
45. Miller JFAP, Osoba D. Current concept of the immunological function of the thymus. Physiol Rev 1967;47:437-520.
46. Tungs KS. Mechanism of self-tolerance and events leading to autoimmune disease and autoantibody response. Clin Immunol Immunopathol 1994;73:275-82.
47. Tungs KS. Elucidation of autoimmune disease mechanism based on testicular and ovarian autoimmune disease models. Horm Metab Res 1995;27:539-43.
48. Tsuchiya M, Asakura H, Yoshimatsu H. Thymic abnormalities and autoimmune diseases. Keito J Med 1989;38:383-402.
49. Bonomo A, Kehn PJ, Shevach EM. Post-thymectomy autoimmunity: abnormal T-cell homeostasis. Immunol Today 1995;16:61-7.
50. Bonomo A, Kehn PJ, Payer E, Rizzo L, Cheever AW, Shevac EM. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J Immunol 1995;154:6602-11.
51. Steinberg AD, Law LD, Talal N. The role of the NZB/NZW F1 thymus in experimental tolerance and auto-immunity. Arthritis Rheum 1970;13:369-77.
52. Penhale WJ, Stumbles PA, Huxtable CR, Sutherland RJ, Pethick DW. Induction of diabetes in PVG/c strain rats by manipulation of the immune system. Autoimmunity 1990;7:169-79.
53. Toh BH, Van-Driel JR, Gleeson PA. Autoimmune gastritis: tolerance and autoimmunity to the gastric H+/K+ ATPase (proton pump). Autoimmunity 1992;13:165-72.
54. Kobashi H, Yamamoto K, Yoshioka T, Tomita M, Tsuji T. Nonsuppurative cholangitis is induced in neonatally thymectomized mice: a possible animal model for primary biliary cirrhosis. Hepatology 1994;19:1424-30.
55. Smith HR, Green DR, Smathers PA, Gershon RK, Raveche ES, Steinberg AD. Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function. Clin Exp Immunol 1983;51:579-86.
56. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995;16:12-6.
57. Cossarizza A, Barbieri D, Londei M. T cell repertoire usage in humans, from newborns to centenarians. Int Rev Immunol 1995;12:41-55.
58. Fabris N, Mocchegiani E, Amadio L, Zannotti M, Licastro F, Franceschi C. Thymic hormone deficiency in normal ageing and Down's syndrome: Is there a primary failure of the thymus? Lancet 1984;1:983-6.
59. Tomer YK, Schonfeld Y. Ageing and autoantibodies. Autoimmunity 1988;1:141-9.
60. Cossarizza A, Ortolani C, Paganelli R, Franceschi C. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to healthy centenarians: implications for T cell memory. Mech Ageing Devel 1996;86:173-95.
61. Tola MR, Caniatti LM, Casetta I, Granieri E, Conighi C, Quatrale R, et al. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy. Acta Neurol Scand 1994;90:318-23.
62. Machens A, Loliger C, Pichlmeier U, Emskotter T, Busch C, Izbicki JR. The impact of HLA on long-term outcome after thymectomy for myasthenia gravis. J Neuroimmunol 1998;88:177-81.